UCB
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With more than 8700 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2022 Key Financials: €5.5 billion global revenue Specialties: Neurology, Immunology
read more
Details
The company has raised a total of $100.8M during its 96 years (about $1M per year). Learn more about Hidden Gem and Efficiency Scores.
Industries
Products
Technologies
Features
The following 0 companies are top matches based on Iterate's Proprietary algorithms.
UCB Highlights
Funding
$100.8M
±0
YoY
Headcount
12.6K
+2K
YoY
Patents
16
±0
YoY
News
100
2 Funding Rounds
Post-IPO Equity
$787.6K
2015-05-13
Investors
Unknown
Post-IPO Equity
$100M
2009-12-22
Investors
Unknown
Add Funding Round
No results found
Try your search again with different filters.